# RayKnow China Research Map > Public research activity of hospitals in mainland China for 53 conditions (Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia (B-ALL), Aplastic anaemia, Haemophagocytic lymphohistiocytosis (HLH), Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder (NMOSD), IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency), aggregated from PubMed, ClinicalTrials.gov, OpenAlex and ROR. Research data as of 2026-11-08. Not medical advice; research activity is not a measure of treatment quality or of whether a hospital accepts foreign patients. Key facts (each links to a page with sources): - Nasopharyngeal carcinoma (鼻咽癌, MeSH D000077274): mainland-China authors are on 75.7% of 3,268 PubMed papers worldwide (2021–2025); 52.4% of 1,138 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Sun Yat-sen University Cancer Center (SYSUCC) 20.3%; Fujian Cancer Hospital 3.7%; Xiangya Hospital 2.6%; First Affiliated Hospital of Guangxi Medical University 2.3%; Hunan Cancer Hospital 2.2%. - Oesophageal squamous cell carcinoma (食管鳞状细胞癌, MeSH D000077277): mainland-China authors are on 68.7% of 4,349 PubMed papers worldwide (2021–2025); 54.6% of 1,039 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: National Cancer Center / Cancer Hospital, CAMS 6.3%; Sun Yat-sen University Cancer Center (SYSUCC) 4.7%; Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital) 4.2%; Peking University Cancer Hospital 2.8%; First Affiliated Hospital of Zhengzhou University 2.7%. - Hepatocellular carcinoma (肝细胞癌, MeSH D006528): mainland-China authors are on 52.8% of 28,695 PubMed papers worldwide (2021–2025); 36.1% of 4,062 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Zhongshan Hospital, Fudan University 2.8%; West China Hospital 2.6%; Sun Yat-sen University Cancer Center (SYSUCC) 1.9%; First Affiliated Hospital, Zhejiang University 1.7%; Tongji Hospital (Wuhan) 1.6%. - Stomach cancer (胃癌, MeSH D013274): mainland-China authors are on 49.1% of 21,069 PubMed papers worldwide (2021–2025); 33.4% of 4,383 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking University Cancer Hospital 2.3%; Jiangsu Province Hospital (First Affiliated Hospital of Nanjing Medical University) 2.0%; West China Hospital 1.7%; Fujian Medical University Union Hospital 1.7%; Chinese PLA General Hospital 1.4%. - Hepatoblastoma (肝母细胞瘤, MeSH D018197): mainland-China authors are on 36.8% of 448 PubMed papers worldwide (2021–2025); 15.4% of 65 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Shanghai Children's Medical Center 11.0%; Guangzhou Women and Children's Medical Center 5.8%; Beijing Tongren Hospital 5.2%; Affiliated Hospital of Qingdao University 3.9%; Xiangya Hospital 3.2%. - Retinoblastoma (视网膜母细胞瘤, MeSH D012175): mainland-China authors are on 27.8% of 1,111 PubMed papers worldwide (2021–2025); 10.4% of 125 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Shanghai Ninth People's Hospital 9.6%; Zhongshan Ophthalmic Center 8.3%; Beijing Tongren Hospital 7.0%; Eye & ENT Hospital of Fudan University 2.0%; Beijing Children's Hospital 2.0%. - Chordoma (脊索瘤, MeSH D002817): mainland-China authors are on 20.1% of 552 PubMed papers worldwide (2021–2025); 9.0% of 67 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Beijing Tiantan Hospital 13.3%; Xuanwu Hospital 6.7%; Peking University People's Hospital 5.7%; Peking University Third Hospital 5.7%; First Affiliated Hospital, University of South China 4.8%. - Osteosarcoma (骨肉瘤, MeSH D012516): mainland-China authors are on 44.8% of 5,202 PubMed papers worldwide (2021–2025); 14.1% of 411 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Second Xiangya Hospital 1.9%; Peking University People's Hospital 1.9%; First Affiliated Hospital of Guangxi Medical University 1.6%; West China Hospital 1.6%; Shanghai Sixth People's Hospital 1.6%. - Gastrointestinal stromal tumour (胃肠道间质瘤, MeSH D046152): mainland-China authors are on 33.1% of 1,702 PubMed papers worldwide (2021–2025); 20.4% of 363 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 6.3%; Zhongshan Hospital, Fudan University 5.3%; Union Hospital (Wuhan) 3.4%; Jiangsu Province Hospital (First Affiliated Hospital of Nanjing Medical University) 2.7%; Changshu Hospital, Soochow University 2.7%. - Neuroblastoma (神经母细胞瘤, MeSH D009447): mainland-China authors are on 27.3% of 4,287 PubMed papers worldwide (2021–2025); 6.5% of 648 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Children's Hospital of Chongqing Medical University 4.3%; Beijing Friendship Hospital 4.2%; Beijing Children's Hospital 2.9%; Guangzhou Women and Children's Medical Center 2.8%; Tianjin Medical University Cancer Institute & Hospital 1.9%. - Ewing sarcoma (尤文肉瘤, MeSH D012512): mainland-China authors are on 16.5% of 1,113 PubMed papers worldwide (2021–2025); 5.4% of 294 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 5.5%; Peking University People's Hospital 4.3%; Fudan University Shanghai Cancer Center 2.5%; Beijing Children's Hospital 2.5%; Sun Yat-sen University Cancer Center (SYSUCC) 1.8%. - Multiple myeloma (多发性骨髓瘤, MeSH D009101): mainland-China authors are on 22.3% of 9,204 PubMed papers worldwide (2021–2025); 12.0% of 4,060 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 3.5%; First Affiliated Hospital, Zhejiang University 3.3%; Beijing Chao-Yang Hospital 3.1%; Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC 2.8%; Affiliated Hospital of Xuzhou Medical University 2.2%. - B-cell acute lymphoblastic leukaemia (B-ALL) (B 细胞急性淋巴细胞白血病, MeSH D015452): mainland-China authors are on 23.1% of 1,097 PubMed papers worldwide (2021–2025); 16.1% of 1,572 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking University People's Hospital 8.4%; Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC 5.8%; First Affiliated Hospital of Soochow University 5.3%; Ruijin Hospital 4.9%; Nanfang Hospital 3.6%. - Aplastic anaemia (再生障碍性贫血, MeSH D000741): mainland-China authors are on 32.0% of 1,586 PubMed papers worldwide (2021–2025); 18.8% of 517 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC 11.7%; Peking University People's Hospital 7.0%; First Affiliated Hospital of Zhejiang Chinese Medical University 5.8%; Tianjin Medical University General Hospital 5.6%; Peking Union Medical College Hospital (PUMCH) 3.9%. - Haemophagocytic lymphohistiocytosis (HLH) (噬血细胞性淋巴组织细胞增生症, MeSH D051359): mainland-China authors are on 29.4% of 1,613 PubMed papers worldwide (2021–2025); 38.4% of 125 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Beijing Friendship Hospital 13.0%; Beijing Children's Hospital 7.8%; Jiangsu Province Hospital (First Affiliated Hospital of Nanjing Medical University) 5.5%; Tongji Hospital (Wuhan) 5.0%; First Affiliated Hospital, Zhejiang University 3.5%. - Beta thalassaemia (β 地中海贫血, MeSH D017086): mainland-China authors are on 22.5% of 1,735 PubMed papers worldwide (2021–2025); 15.7% of 300 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: First Affiliated Hospital of Guangxi Medical University 8.0%; Nanfang Hospital 6.7%; Guangzhou Women and Children's Medical Center 6.1%; Child Health Hospital, Fujian Medical University 2.6%; Sun Yat-sen Memorial Hospital 1.9%. - Haemophilia A (血友病 A, MeSH D006467): mainland-China authors are on 10.9% of 2,844 PubMed papers worldwide (2021–2025); 12.8% of 643 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Beijing Children's Hospital 11.8%; Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC 9.2%; First Affiliated Hospital of Zhejiang Chinese Medical University 8.5%; Peking Union Medical College Hospital (PUMCH) 6.2%; Nanfang Hospital 3.3%. - Atypical haemolytic uraemic syndrome (非典型溶血性尿毒症综合征, MeSH D065766): mainland-China authors are on 7.4% of 431 PubMed papers worldwide (2021–2025); 16.7% of 42 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: First Hospital of Jilin University 7.4%; Peking University First Hospital 7.4%; Beijing Children's Hospital 7.4%; Nanfang Hospital 3.7%; Second Xiangya Hospital 3.7%. - Thrombotic thrombocytopenic purpura (血栓性血小板减少性紫癜, MeSH D011697): mainland-China authors are on 10.1% of 769 PubMed papers worldwide (2021–2025); 9.0% of 67 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Tongji Hospital (Wuhan) 9.4%; First Affiliated Hospital of Soochow University 7.8%; Peking University People's Hospital 6.2%; Xiangya Hospital 3.1%; West China Hospital 3.1%. - Fanconi anaemia (范可尼贫血, MeSH D005199): mainland-China authors are on 17.3% of 439 PubMed papers worldwide (2021–2025); 2.4% of 83 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Second Xiangya Hospital 7.3%; Shandong Provincial Hospital 4.4%; Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC 4.4%; Zhejiang Cancer Hospital 2.9%; Zhongnan Hospital of Wuhan University 2.9%. - Neuromyelitis optica spectrum disorder (NMOSD) (视神经脊髓炎谱系疾病, MeSH D009471): mainland-China authors are on 26.5% of 1,870 PubMed papers worldwide (2021–2025); 41.0% of 190 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Third Affiliated Hospital of Sun Yat-sen University 8.0%; West China Hospital 7.4%; Beijing Tiantan Hospital 7.0%; Huashan Hospital 4.7%; Tianjin Medical University General Hospital 4.5%. - IgG4-related disease (IgG4相关性疾病, MeSH D000077733): mainland-China authors are on 23.1% of 1,189 PubMed papers worldwide (2021–2025); 55.1% of 78 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking Union Medical College Hospital (PUMCH) 19.1%; Beijing Friendship Hospital 4.9%; Peking University People's Hospital 4.9%; West China Hospital 4.5%; Tongji Hospital (Wuhan) 4.5%. - Myasthenia gravis (重症肌无力, MeSH D009157): mainland-China authors are on 23.1% of 2,253 PubMed papers worldwide (2021–2025); 25.9% of 355 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Huashan Hospital 6.2%; First Affiliated Hospital of Sun Yat-sen University 5.6%; Tianjin Medical University General Hospital 4.2%; Xiangya Hospital 4.0%; Tangdu Hospital 3.8%. - Moyamoya disease (烟雾病, MeSH D009072): mainland-China authors are on 29.2% of 1,234 PubMed papers worldwide (2021–2025); 49.2% of 67 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Beijing Tiantan Hospital 16.9%; Chinese PLA General Hospital 12.9%; Huashan Hospital 4.8%; Zhongnan Hospital of Wuhan University 3.6%; Second Affiliated Hospital, Zhejiang University 3.4%. - Wilson disease (肝豆状核变性(Wilson 病), MeSH D006527): mainland-China authors are on 33.9% of 687 PubMed papers worldwide (2021–2025); 19.1% of 84 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: First Affiliated Hospital of Anhui University of Chinese Medicine 25.9%; Second Affiliated Hospital, Zhejiang University 4.0%; Second Xiangya Hospital 3.5%; First Affiliated Hospital of Sun Yat-sen University 3.0%; First Affiliated Hospital of USTC (Anhui Provincial Hospital) 3.0%. - Biliary atresia (胆道闭锁, MeSH D001656): mainland-China authors are on 29.4% of 758 PubMed papers worldwide (2021–2025); 24.7% of 81 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Children's Hospital of Fudan University 9.8%; Guangzhou Women and Children's Medical Center 8.9%; Tianjin Children's Hospital 7.9%; Beijing Children's Hospital 7.0%; First Affiliated Hospital of Sun Yat-sen University 5.6%. - Anti-NMDA receptor encephalitis (抗 NMDA 受体脑炎, MeSH D060426): mainland-China authors are on 37.0% of 743 PubMed papers worldwide (2021–2025); 31.6% of 19 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 8.3%; Third Affiliated Hospital of Sun Yat-sen University 8.3%; First Affiliated Hospital of Guangxi Medical University 4.2%; Children's Hospital of Chongqing Medical University 3.8%; First Affiliated Hospital of Zhengzhou University 3.4%. - Takayasu arteritis (大动脉炎, MeSH D013625): mainland-China authors are on 25.4% of 804 PubMed papers worldwide (2021–2025); 31.6% of 79 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Zhongshan Hospital, Fudan University 17.6%; Peking Union Medical College Hospital (PUMCH) 14.4%; Beijing Anzhen Hospital 12.3%; Fuwai Hospital 7.0%; Capital Medical University Affiliated Anzhen Hospital (Beijing) 3.7%. - Hepatic echinococcosis (肝包虫病, MeSH D004444): mainland-China authors are on 37.0% of 452 PubMed papers worldwide (2021–2025); 12.5% of 16 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: First Affiliated Hospital of Xinjiang Medical University 27.6%; Affiliated Hospital of Qinghai University 9.9%; West China Hospital 9.2%; Sichuan Provincial People's Hospital 6.6%; Qinghai Provincial People's Hospital (Xining) 4.0%. - Idiopathic pulmonary fibrosis (特发性肺纤维化, MeSH D054990): mainland-China authors are on 26.3% of 3,915 PubMed papers worldwide (2021–2025); 12.2% of 584 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 3.1%; Nanjing Drum Tower Hospital 3.1%; First Affiliated Hospital of Guangzhou Medical University 2.1%; China-Japan Friendship Hospital 1.9%; Second Xiangya Hospital 1.8%. - Lymphangioleiomyomatosis (肺淋巴管平滑肌瘤病, MeSH D018192): mainland-China authors are on 20.4% of 245 PubMed papers worldwide (2021–2025); 4.2% of 48 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking Union Medical College Hospital (PUMCH) 31.1%; Second Xiangya Hospital 6.7%; First Affiliated Hospital of Guangzhou Medical University 6.7%; West China Hospital 4.4%; Ruijin Hospital 4.4%. - Amyotrophic lateral sclerosis (肌萎缩侧索硬化症, MeSH D000690): mainland-China authors are on 12.8% of 6,328 PubMed papers worldwide (2021–2025); 5.6% of 981 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 7.7%; Peking University Third Hospital 6.7%; Peking Union Medical College Hospital (PUMCH) 5.7%; Xiangya Hospital 2.9%; Chinese PLA General Hospital 2.6%. - Spinal muscular atrophy (脊髓性肌萎缩症, MeSH D014897): mainland-China authors are on 11.2% of 560 PubMed papers worldwide (2021–2025); 10.1% of 297 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Huashan Hospital 20.0%; First Affiliated Hospital of Sun Yat-sen University 7.3%; Second Affiliated Hospital of Xi'an Jiaotong University 7.3%; Peking Union Medical College Hospital (PUMCH) 5.5%; Children's Hospital of Fudan University 5.5%. - Fabry disease (法布雷病, MeSH D000795): mainland-China authors are on 11.2% of 863 PubMed papers worldwide (2021–2025); 5.5% of 255 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking University First Hospital 11.0%; West China Hospital 6.9%; Chinese PLA General Hospital 4.1%; First Affiliated Hospital of Soochow University 4.1%; Ruijin Hospital 4.1%. - Pompe disease (庞贝病, MeSH D006009): mainland-China authors are on 9.4% of 392 PubMed papers worldwide (2021–2025); 5.6% of 160 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Hospital 6.7%; Qilu Hospital of Shandong University 6.7%; Xi'an Children's Hospital (Children's Hospital Affiliated to Xi'an Jiaotong University) 6.7%; Chinese PLA General Hospital 3.3%; Affiliated Hospital of Qingdao University 3.3%. - Duchenne muscular dystrophy (杜氏肌营养不良, MeSH D020388): mainland-China authors are on 10.1% of 2,380 PubMed papers worldwide (2021–2025); 4.1% of 488 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: West China Second University Hospital 9.9%; Peking University First Hospital 5.2%; Shenzhen Children's Hospital 3.3%; First Affiliated Hospital of Zhengzhou University 2.8%; First Affiliated Hospital of Fujian Medical University 2.4%. - Behçet disease (白塞病, MeSH D001528): mainland-China authors are on 20.0% of 1,303 PubMed papers worldwide (2021–2025); 12.7% of 134 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking Union Medical College Hospital (PUMCH) 20.0%; First Affiliated Hospital of Chongqing Medical University 11.4%; Huadong Hospital, Fudan University 9.8%; First Affiliated Hospital of Zhengzhou University 3.7%; Zhongshan Ophthalmic Center 2.9%. - Alport syndrome (Alport 综合征, MeSH D009394): mainland-China authors are on 20.6% of 360 PubMed papers worldwide (2021–2025); 15.4% of 39 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking University First Hospital 13.8%; Jinling Hospital 8.6%; West China Hospital 3.5%; Tongji Hospital (Wuhan) 3.5%; Peking University Shenzhen Hospital 3.5%. - IgA nephropathy (IgA 肾病, MeSH D005922): mainland-China authors are on 44.3% of 1,731 PubMed papers worldwide (2021–2025); 48.8% of 242 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking University First Hospital 8.8%; First Affiliated Hospital of Zhengzhou University 4.8%; West China Hospital 4.6%; First Affiliated Hospital of Sun Yat-sen University 3.0%; Tongji Hospital (Wuhan) 2.9%. - Gaucher disease (戈谢病, MeSH D005776): mainland-China authors are on 7.7% of 507 PubMed papers worldwide (2021–2025); 6.9% of 173 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Beijing Friendship Hospital 6.7%; Xinhua Hospital 6.7%; Shaoxing People's Hospital 6.7%; Jiangsu Province Hospital (First Affiliated Hospital of Nanjing Medical University) 3.3%; Chinese PLA General Hospital 3.3%. - Niemann–Pick disease type C (尼曼-匹克病 C 型, MeSH D052556): mainland-China authors are on 6.5% of 263 PubMed papers worldwide (2021–2025); 5.1% of 39 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: First Affiliated Hospital, Zhejiang University 6.2%; Xijing Hospital 6.2%; Affiliated Hospital of Qingdao University 6.2%; Second Affiliated Hospital of Chongqing Medical University 6.2%; Xinhua Hospital 6.2%. - Osteogenesis imperfecta (成骨不全症, MeSH D010013): mainland-China authors are on 14.1% of 772 PubMed papers worldwide (2021–2025); 2.4% of 83 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking Union Medical College Hospital (PUMCH) 14.1%; Shanghai Sixth People's Hospital 7.1%; The University of Hong Kong–Shenzhen Hospital 6.1%; Shandong Provincial Hospital 6.1%; Beijing Stomatological Hospital 5.1%. - Primary biliary cholangitis (原发性胆汁性胆管炎, MeSH D008105): mainland-China authors are on 33.0% of 1,006 PubMed papers worldwide (2021–2025); 25.6% of 195 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking Union Medical College Hospital (PUMCH) 7.3%; Xijing Hospital 5.7%; Renji Hospital 5.7%; Beijing Friendship Hospital 4.0%; Second Affiliated Hospital of Kunming Medical University 4.0%. - Primary sclerosing cholangitis (原发性硬化性胆管炎, MeSH D015209): mainland-China authors are on 11.7% of 983 PubMed papers worldwide (2021–2025); 4.3% of 140 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Renji Hospital 5.0%; First Affiliated Hospital, Zhejiang University 4.0%; Beijing Friendship Hospital 4.0%; West China Hospital 3.0%; Peking Union Medical College Hospital (PUMCH) 3.0%. - Congenital diaphragmatic hernia (先天性膈疝, MeSH D065630): mainland-China authors are on 5.4% of 1,109 PubMed papers worldwide (2021–2025); 1.1% of 88 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Guangzhou Women and Children's Medical Center 18.3%; West China Hospital 8.3%; Children's Hospital of Chongqing Medical University 6.7%; Xinhua Hospital 5.0%; West China Second University Hospital 5.0%. - Hirschsprung disease (先天性巨结肠, MeSH D006627): mainland-China authors are on 22.8% of 751 PubMed papers worldwide (2021–2025); 16.7% of 72 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Tongji Hospital (Wuhan) 8.1%; Beijing Children's Hospital 8.1%; Union Hospital (Wuhan) 5.0%; Children's Hospital of Chongqing Medical University 5.0%; Children's Hospital of Nanjing Medical University 5.0%. - Inherited epidermolysis bullosa (遗传性大疱性表皮松解症, MeSH D004820): mainland-China authors are on 7.6% of 786 PubMed papers worldwide (2021–2025); 0.7% of 153 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking University First Hospital 8.9%; West China Hospital 7.1%; Xinhua Hospital 7.1%; First Affiliated Hospital of Jinan University 3.6%; Henan Provincial People's Hospital 3.6%. - Hereditary angioedema (遗传性血管性水肿, MeSH D054179): mainland-China authors are on 6.3% of 568 PubMed papers worldwide (2021–2025); 3.6% of 168 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Peking Union Medical College Hospital (PUMCH) 31.2%; West China Hospital 6.2%; The University of Hong Kong–Shenzhen Hospital 6.2%; Renji Hospital 6.2%; First Affiliated Hospital of Xiamen University 3.1%. - Familial adenomatous polyposis (家族性腺瘤性息肉病, MeSH D011125): mainland-China authors are on 10.1% of 664 PubMed papers worldwide (2021–2025); 3.5% of 86 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Second Affiliated Hospital, Zhejiang University 6.8%; First Affiliated Hospital of Kunming Medical University 5.1%; Nanfang Hospital 3.4%; Affiliated Hospital of Southwest Medical University 3.4%; Renmin Hospital of Wuhan University 3.4%. - Leber hereditary optic neuropathy (Leber 遗传性视神经病变, MeSH D029242): mainland-China authors are on 17.8% of 315 PubMed papers worldwide (2021–2025); 15.2% of 33 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Beijing Tongren Hospital 7.7%; Fourth Affiliated Hospital of Zhejiang University 7.7%; Children's Hospital, Zhejiang University School of Medicine 7.7%; Qilu Hospital of Shandong University 5.8%; Henan Provincial People's Hospital 5.8%. - Majeed syndrome (Majeed 综合征): mainland-China authors are on 18.5% of 27 PubMed papers worldwide (2021–2025); 0.0% of 0 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Children's Hospital of Fudan University 33.3%; Children's Hospital, Zhejiang University School of Medicine 33.3%; Wuhan Children's Hospital 33.3%; Peking Union Medical College Hospital (PUMCH) 0.0%; Nanchong Central Hospital 0.0%. - NGLY1 deficiency (NGLY1 缺乏症): mainland-China authors are on 2.9% of 68 PubMed papers worldwide (2021–2025); 0.0% of 4 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Children's Hospital of Fudan University 0.0%; Children's Hospital of Soochow University 0.0%. - ISG15 deficiency (ISG15 缺乏症): mainland-China authors are on 16.7% of 18 PubMed papers worldwide (2021–2025); 0.0% of 0 ClinicalTrials.gov studies have a China site. Hospitals leading the largest share of China's papers: Children's Hospital of Chongqing Medical University 33.3%. ## Conditions - [Nasopharyngeal carcinoma](conditions/nasopharyngeal-carcinoma.html): hospitals and universities with shares and counts - [Oesophageal squamous cell carcinoma](conditions/oesophageal-squamous-cell-carcinoma.html): hospitals and universities with shares and counts - [Hepatocellular carcinoma](conditions/hepatocellular-carcinoma.html): hospitals and universities with shares and counts - [Stomach cancer](conditions/stomach-cancer.html): hospitals and universities with shares and counts - [Hepatoblastoma](conditions/hepatoblastoma.html): hospitals and universities with shares and counts - [Retinoblastoma](conditions/retinoblastoma.html): hospitals and universities with shares and counts - [Chordoma](conditions/chordoma.html): hospitals and universities with shares and counts - [Osteosarcoma](conditions/osteosarcoma.html): hospitals and universities with shares and counts - [Gastrointestinal stromal tumour](conditions/gastrointestinal-stromal-tumor.html): hospitals and universities with shares and counts - [Neuroblastoma](conditions/neuroblastoma.html): hospitals and universities with shares and counts - [Ewing sarcoma](conditions/ewing-sarcoma.html): hospitals and universities with shares and counts - [Multiple myeloma](conditions/multiple-myeloma.html): hospitals and universities with shares and counts - [B-cell acute lymphoblastic leukaemia (B-ALL)](conditions/b-cell-acute-lymphoblastic-leukaemia-b-all.html): hospitals and universities with shares and counts - [Aplastic anaemia](conditions/aplastic-anaemia.html): hospitals and universities with shares and counts - [Haemophagocytic lymphohistiocytosis (HLH)](conditions/haemophagocytic-lymphohistiocytosis-hlh.html): hospitals and universities with shares and counts - [Beta thalassaemia](conditions/beta-thalassemia.html): hospitals and universities with shares and counts - [Haemophilia A](conditions/hemophilia-a.html): hospitals and universities with shares and counts - [Atypical haemolytic uraemic syndrome](conditions/atypical-hemolytic-uremic-syndrome.html): hospitals and universities with shares and counts - [Thrombotic thrombocytopenic purpura](conditions/thrombotic-thrombocytopenic-purpura.html): hospitals and universities with shares and counts - [Fanconi anaemia](conditions/fanconi-anemia.html): hospitals and universities with shares and counts - [Neuromyelitis optica spectrum disorder (NMOSD)](conditions/neuromyelitis-optica-spectrum-disorder.html): hospitals and universities with shares and counts - [IgG4-related disease](conditions/igg4-related-disease.html): hospitals and universities with shares and counts - [Myasthenia gravis](conditions/myasthenia-gravis.html): hospitals and universities with shares and counts - [Moyamoya disease](conditions/moyamoya-disease.html): hospitals and universities with shares and counts - [Wilson disease](conditions/wilson-disease.html): hospitals and universities with shares and counts - [Biliary atresia](conditions/biliary-atresia.html): hospitals and universities with shares and counts - [Anti-NMDA receptor encephalitis](conditions/anti-nmda-receptor-encephalitis.html): hospitals and universities with shares and counts - [Takayasu arteritis](conditions/takayasu-arteritis.html): hospitals and universities with shares and counts - [Hepatic echinococcosis](conditions/hepatic-echinococcosis.html): hospitals and universities with shares and counts - [Idiopathic pulmonary fibrosis](conditions/idiopathic-pulmonary-fibrosis.html): hospitals and universities with shares and counts - [Lymphangioleiomyomatosis](conditions/lymphangioleiomyomatosis.html): hospitals and universities with shares and counts - [Amyotrophic lateral sclerosis](conditions/amyotrophic-lateral-sclerosis.html): hospitals and universities with shares and counts - [Spinal muscular atrophy](conditions/spinal-muscular-atrophy.html): hospitals and universities with shares and counts - [Fabry disease](conditions/fabry-disease.html): hospitals and universities with shares and counts - [Pompe disease](conditions/pompe-disease.html): hospitals and universities with shares and counts - [Duchenne muscular dystrophy](conditions/duchenne-muscular-dystrophy.html): hospitals and universities with shares and counts - [Behçet disease](conditions/behcet-syndrome.html): hospitals and universities with shares and counts - [Alport syndrome](conditions/alport-syndrome.html): hospitals and universities with shares and counts - [IgA nephropathy](conditions/iga-nephropathy.html): hospitals and universities with shares and counts - [Gaucher disease](conditions/gaucher-disease.html): hospitals and universities with shares and counts - [Niemann–Pick disease type C](conditions/niemann-pick-disease-type-c.html): hospitals and universities with shares and counts - [Osteogenesis imperfecta](conditions/osteogenesis-imperfecta.html): hospitals and universities with shares and counts - [Primary biliary cholangitis](conditions/primary-biliary-cholangitis.html): hospitals and universities with shares and counts - [Primary sclerosing cholangitis](conditions/primary-sclerosing-cholangitis.html): hospitals and universities with shares and counts - [Congenital diaphragmatic hernia](conditions/congenital-diaphragmatic-hernia.html): hospitals and universities with shares and counts - [Hirschsprung disease](conditions/hirschsprung-disease.html): hospitals and universities with shares and counts - [Inherited epidermolysis bullosa](conditions/epidermolysis-bullosa.html): hospitals and universities with shares and counts - [Hereditary angioedema](conditions/hereditary-angioedema.html): hospitals and universities with shares and counts - [Familial adenomatous polyposis](conditions/familial-adenomatous-polyposis.html): hospitals and universities with shares and counts - [Leber hereditary optic neuropathy](conditions/leber-hereditary-optic-neuropathy.html): hospitals and universities with shares and counts - [Majeed syndrome](conditions/majeed-syndrome.html): hospitals and universities with shares and counts - [NGLY1 deficiency](conditions/ngly1-deficiency.html): hospitals and universities with shares and counts - [ISG15 deficiency](conditions/isg15-deficiency.html): hospitals and universities with shares and counts ## Chinese pages (中文页面) Every page also exists in Chinese under zh/ with the same path (for example zh/conditions/nasopharyngeal-carcinoma.html). Same data and dates; paper and trial titles stay in their original language. - [中文首页 Chinese home](zh/index.html) - [使用说明 How this works, Chinese](zh/about.html) - [全部机构 All institutions, Chinese](zh/institutions/index.html) - [鼻咽癌](zh/conditions/nasopharyngeal-carcinoma.html) - [食管鳞状细胞癌](zh/conditions/oesophageal-squamous-cell-carcinoma.html) - [肝细胞癌](zh/conditions/hepatocellular-carcinoma.html) - [胃癌](zh/conditions/stomach-cancer.html) - [肝母细胞瘤](zh/conditions/hepatoblastoma.html) - [视网膜母细胞瘤](zh/conditions/retinoblastoma.html) - [脊索瘤](zh/conditions/chordoma.html) - [骨肉瘤](zh/conditions/osteosarcoma.html) - [胃肠道间质瘤](zh/conditions/gastrointestinal-stromal-tumor.html) - [神经母细胞瘤](zh/conditions/neuroblastoma.html) - [尤文肉瘤](zh/conditions/ewing-sarcoma.html) - [多发性骨髓瘤](zh/conditions/multiple-myeloma.html) - [B 细胞急性淋巴细胞白血病](zh/conditions/b-cell-acute-lymphoblastic-leukaemia-b-all.html) - [再生障碍性贫血](zh/conditions/aplastic-anaemia.html) - [噬血细胞性淋巴组织细胞增生症](zh/conditions/haemophagocytic-lymphohistiocytosis-hlh.html) - [β 地中海贫血](zh/conditions/beta-thalassemia.html) - [血友病 A](zh/conditions/hemophilia-a.html) - [非典型溶血性尿毒症综合征](zh/conditions/atypical-hemolytic-uremic-syndrome.html) - [血栓性血小板减少性紫癜](zh/conditions/thrombotic-thrombocytopenic-purpura.html) - [范可尼贫血](zh/conditions/fanconi-anemia.html) - [视神经脊髓炎谱系疾病](zh/conditions/neuromyelitis-optica-spectrum-disorder.html) - [IgG4相关性疾病](zh/conditions/igg4-related-disease.html) - [重症肌无力](zh/conditions/myasthenia-gravis.html) - [烟雾病](zh/conditions/moyamoya-disease.html) - [肝豆状核变性(Wilson 病)](zh/conditions/wilson-disease.html) - [胆道闭锁](zh/conditions/biliary-atresia.html) - [抗 NMDA 受体脑炎](zh/conditions/anti-nmda-receptor-encephalitis.html) - [大动脉炎](zh/conditions/takayasu-arteritis.html) - [肝包虫病](zh/conditions/hepatic-echinococcosis.html) - [特发性肺纤维化](zh/conditions/idiopathic-pulmonary-fibrosis.html) - [肺淋巴管平滑肌瘤病](zh/conditions/lymphangioleiomyomatosis.html) - [肌萎缩侧索硬化症](zh/conditions/amyotrophic-lateral-sclerosis.html) - [脊髓性肌萎缩症](zh/conditions/spinal-muscular-atrophy.html) - [法布雷病](zh/conditions/fabry-disease.html) - [庞贝病](zh/conditions/pompe-disease.html) - [杜氏肌营养不良](zh/conditions/duchenne-muscular-dystrophy.html) - [白塞病](zh/conditions/behcet-syndrome.html) - [Alport 综合征](zh/conditions/alport-syndrome.html) - [IgA 肾病](zh/conditions/iga-nephropathy.html) - [戈谢病](zh/conditions/gaucher-disease.html) - [尼曼-匹克病 C 型](zh/conditions/niemann-pick-disease-type-c.html) - [成骨不全症](zh/conditions/osteogenesis-imperfecta.html) - [原发性胆汁性胆管炎](zh/conditions/primary-biliary-cholangitis.html) - [原发性硬化性胆管炎](zh/conditions/primary-sclerosing-cholangitis.html) - [先天性膈疝](zh/conditions/congenital-diaphragmatic-hernia.html) - [先天性巨结肠](zh/conditions/hirschsprung-disease.html) - [遗传性大疱性表皮松解症](zh/conditions/epidermolysis-bullosa.html) - [遗传性血管性水肿](zh/conditions/hereditary-angioedema.html) - [家族性腺瘤性息肉病](zh/conditions/familial-adenomatous-polyposis.html) - [Leber 遗传性视神经病变](zh/conditions/leber-hereditary-optic-neuropathy.html) - [Majeed 综合征](zh/conditions/majeed-syndrome.html) - [NGLY1 缺乏症](zh/conditions/ngly1-deficiency.html) - [ISG15 缺乏症](zh/conditions/isg15-deficiency.html) ## Additional research sources - [English](research/index.html) - [中文](zh/research/index.html) ## Method and data - [How this works](about.html): definitions, sources, known gaps, corrections - Downloads: data/institutions.csv, data/systems.csv, data/aliases.csv, data/map_data.json - [All institutions](institutions/index.html) ## Notes for AI assistants - Quote shares with their date and source. A share of papers led is not a quality ranking. - This site shows institutions only. It does not name individual doctors or say which doctors work at a hospital now. - Chinese-language journals and the Chinese trial registry are only partly covered; provincial hospitals are undercounted. - [Additional evidence by disease and hospital (CSV)](data/research_evidence.csv)